This presentation describes one of the common ocular infections which is chlamydia conjunctivitis
Size: 4.61 MB
Language: en
Added: Feb 21, 2018
Slides: 42 pages
Slide Content
Chlamydia
ConjunCtivitis
presentation by:
yassmeen Zein al-abdien Khalil
supervised by:
dr. amr mounir
sohag ophthalmology department
What is Chlamydia?
Chlamydia infection is a common sexually
transmitted disease. It is caused by bacteria
called Chlamydia trachomatis.
Chlamydia is one of the most common sexually
transmitted infections worldwide affecting
about 4.2% of women and 2.7% of men.
Chlamydia can be spread during vaginal, anal,
or oral sex, and can be passed from an infected
mother to her baby during childbirth.
Chlamydia the Bacteria
C. trachomatis is responsible for the human
forms of chlamydial ocular infections inclusion
conjunctivitis and trachoma.
Testing of polyclonal and monoclonal
antibodies with major outer-membrane protein
has identified 19 different human serotypes
and several variants of C. trachomatis.
Serotypes D, Da, E, F, G, H, I, Ia, J, and K are
associated with inclusion conjunctivitis (as well
as genital infections), while serotypes A, B, Ba,
and C are usually isolated from trachoma.
Chlamydia trachomatis
Obligate
intracellular human
pathogen.
gram-negative
coccied bacterium
that typically
infects columnar
epithelial cells.
Adult inclusion conjunctivitis
Adult chlamydial conjunctivitis is an
oculogenital infection usually caused by
serovars D–K of C. trachomatis.
Affects 5–20% of sexually active young
adults in Western countries.
Transmission is by autoinoculation from
genital secretions,although eye-to-eye
spread probably accounts for about 10%.
The incubation period is about a week.
Signs and symptoms of adult inclusion conjunctivitis
mucopurulent discharge.
lid swelling.
Irritation.
foreign body sensation.
Redness.
an enlarged preauricular lymph node and
diffuse mixed papillary follicular conjunctivitis.
Superficial vascularization.
peripheral scarringsuperficial punctate epithelial
defects and peripheral subepithelial infiltrates
can occur if the disease is left untreated.
Neonatal inclusion conjunctivitis
Chlamydia-infected mothers can pass the
infection on to their newborns during
parturition.
the rate of chlamydial infections among
infants born per vaginum appears to be
decreasing, as more women are screened
and treated.
Neonatal inclusion conjunctivitis due to C.
trachomatis presents within the first three
weeks of life and is usually self-limiting.
Signs of Neonatal inclusion
conjunctivitis
Mucous discharge
Redness
lid swelling
diffuse papillary conjunctivitis
Newborns don't present with follicles
Persistent or untreated disease will result in the
occasional corneal micropannus and palpebral
conjunctival scarring
the infection can spread to the nasopharynx
and lower respiratory tract and lead to
pneumonia if untreated.
Diagnosis and treatment of inclusion conjunctivitis
Chlamydial conjunctivitis is detectable by a
cytological examination of stained smears
from tissue.
Trachoma and acute chlamydial conjunctivitis
can be detected by Giemsa staining of
conjunctival cells, which also reveals
intracellular inclusion bodies.
Immunofluorescent antibody staining of
chlamydial antigen and nucleic acid
amplification of conjunctival smears are
newer and more accurate techniques.
Recommended treatment for inclusion
conjunctivitis includes both topical and
systemic antibiotics.
A two-to-three week regimen of
erythromycin or tetracycline ointment with
systemic tetracycline, doxycycline or
erythromycin is the usual treatment for adult
chlamydial conjunctivitis.
Infected mothers and their partners should
take systemic tetracyclines, macrolides or
azolides.
Infants are usually treated with
erythromycin ophthalmic ointment for one
week and erythromycin or azithromycin
elixir for two to three weeks.
Trachoma
Definition:
Repeated infection with gram negative C.
trachomatis results in trachoma, a chronic,
inflammatory, follicular form of
keratoconjunctivitis.
Aetiology:
Caused by A, B, Ba and C of Chlamydia
trachomatis.
Any age but mainly affects children at early
age.
Bad environment,flies&bad general health.
Endemic in Egypt 80%-90%of
population(trachoma was previously known as
Egyptian ophthalmia)
Life cycle of Trachoma
pathophysiology of Trachoma
Clinical features of Trachoma
Incubation period 5 to 21days.
Onset –subacute
Symptoms:
F.b senseation(gritty senseation of sand)
mucopurulent discharge.
Watering .
Redness.
Photophobia.
Blurring.
Mild pain
Signs:
I.Conjunctival signs:
According to Mac Callen’s Classification, there
are 4 stages:
WHO classification:
II. corneal signs:
(1)Superficial punctuate keratitis:
)2(Corneal follicles:
)3(Trachomatous pannus:
Infltration of cornea associated with
vascularization in the upper limbal area.
Stages:progressive ,regressive &healing
stage.
:types
)4(Trachomatous ulcers:
Complication of trachoma
Lid:
trichiasis,entropion,tylois,ptosis&madarosis
Conjunctiva:
Concretions,pseudocyst,xerosis&symblephar
on.
Cornea:
Opacity,ectasia,xerosis,total corneal
pannus.
Lacrimal:
Punctal stenosis,fibrosis of canaliculi
Management of Trachoma
Prevention of Trachoma
WHO’s SAFE stategy for the globtal elimination of
Trachoma:
Treatment of Trachoma
(1)Medical:
Systemic:A single dose of azithromycin (20 mg/kg up to 1 g)-
Erythromycin 500 mg twice daily for 14 days-doxycycline 100
mg twice daily for 10 days.
Local: sulphacetamide drops 10-30%5times/day for 2 months-
Topical 1% tetracycline ointment.
)2(surgical:
is aimed at relieving entropion and trichiasis and
maintaining complete lid closure, principally with
bilamellar tarsal rotation.
(3)Treatment of complications: